HFS
PJP icon

Hantz Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Hantz Financial Services’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Hold
116
– – ﹤0.01% 2005
2025
Q4 		$12K Buy
+116
New +$11.7K ﹤0.01% 1950

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hantz Financial Services's PJP Position: Q1 2026 in Review

Hantz Financial Services held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 116 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

Hantz Financial Services first reported a position in PJP in Q4 2025 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Hantz Financial Services held 116 shares of Invesco Pharmaceuticals ETF worth $12K as of Q1 2026.
  • Hantz Financial Services left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2005 holding.
  • Hantz Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2025 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.